AGA Medical Holdings, Inc. (AGA Medical) (Nasdaq: AGAM) today announced that the company is scheduled to present at the BMO Capital Markets 10th Annual Focus on Healthcare Conference being held at the Sheraton New York Hotel & Towers in New York City on Thursday, August 5, 2010, at 3:00 p.m. ET. John Barr, President and Chief Executive Officer, will deliver the company's presentation.

To access the webcast, please go to the investor relations section of the AGA Medical website (www.amplatzer.com) and click on the webcast icon under the ?IR Calendar? section.

About AGA Medical

AGA Medical, based in Plymouth, Minnesota, is a leading innovator and manufacturer of medical devices for the treatment of structural heart defects and vascular abnormalities. AGA Medical's AMPLATZER® occlusion devices offer minimally invasive, transcatheter treatments that have been clinically shown to be safe and highly effective in defect closure. AGA Medical is the only manufacturer with occlusion devices approved to close seven different structural heart defects, with leading market positions for each of its devices. More than 1,650 articles supporting the benefits of AMPLATZER products have been published in medical literature. AGA Medical markets its AMPLATZER products in 112 countries worldwide to interventional cardiologists, electrophysiologists, interventional radiologists and vascular surgeons. More information about the company and its products can be found at http://www.amplatzer.com.

AGA Medical
Rachel Ellingson, 763-531-3018
Senior Director, Business Development
and Investor Relations
rellingson@amplatzer.com